Cargando…
Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19
Background: Tocilizumab is used in severe COVID-19 yet has significant rates of treatment failure. Objectives: This retrospective study aimed to identify early predictors of the response to tocilizumab therapy. Methods: Biochemical and clinical characteristics of adult patients who received tocilizu...
Autores principales: | Singla, Karan, Puri, Goverdhan D, Guha Niyogi, Subhrashis, Mahajan, Varun, Kajal, Kamal, Bhalla, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509663/ https://www.ncbi.nlm.nih.gov/pubmed/36176874 http://dx.doi.org/10.7759/cureus.28428 |
Ejemplares similares
-
Factors Associated With Non-invasive Oxygen Therapy Failure in COVID-19 Pneumonia: A Single Center, Retrospective Study in a Tertiary Hospital in North India
por: L, Sekar, et al.
Publicado: (2022) -
Effect of head-end of bed elevation on respiratory mechanics in mechanically ventilated patients with moderate-to-severe COVID-19 ARDS – A cohort study
por: Ray, Ananya, et al.
Publicado: (2022) -
Does Arterial Blood Gas (ABG) Provide a Safety Net for Extubation in Surgical Patients?
por: Hazarika, Amarjyoti, et al.
Publicado: (2023) -
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
por: Naik, Naveen B, et al.
Publicado: (2021) -
COVID-19 and Acute Kidney Injury: Point-of-care Ultrasound in the Assessment of Volume Status
por: Guha Niyogi, Subhrashis, et al.
Publicado: (2021)